Alogliptin D9
| Product Name | Alogliptin D9 |
|---|---|
| Alternate Names | Alogliptin Stable Isotopes, Stable Isotopes of Alogliptin |
| CAT No. | CS-CX-00081 |
| CAS No. | 1133421-33-6 |
| Category | Stable Isotopes |
| Stock | Enquire |
| Mol. Wt. | Not Available |
| Mol. For. | Not Available |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Alogliptin |
| Smileys | O=C(N1C)N(C(N(C([2H])([2H])C([2H])([2H])C2([2H])[2H])C([2H])([2H])[C@]2([2H])N)=CC1=O)CC(C=CC=C3)=C3C#N |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Alogliptin D9 is a medication used for the treatment of type 2 diabetes. It works by inhibiting the enzyme dipeptidyl peptidase-4 (DPP-4), which is responsible for breaking down the hormone incretin. Incretin helps to stimulate insulin secretion and reduce glucose production in the liver, leading to better blood sugar control.
Alogliptin D9 is a stable isotope of alogliptin, which is a DPP-4 inhibitor. The D9 designation indicates that the molecule contains nine deuterium atoms, which are isotopes of hydrogen with a higher atomic mass. This makes Alogliptin D9 useful in pharmacokinetic studies, as it can be used to track the metabolism and elimination of alogliptin in the body.
The chemical formula of Alogliptin D9 is C18H17F2N5O•D9. It has a molecular weight of 333.4 g/mol. The medication is available in tablet form for oral administration, with a recommended dose of 25 mg once daily. Alogliptin D9 is generally well-tolerated, with common side effects including headache, upper respiratory tract infection, and nasopharyngitis.
In conclusion, Alogliptin D9 is a medication used for the treatment of type 2 diabetes. It works by inhibiting the enzyme dipeptidyl peptidase-4, leading to better blood sugar control. Its stable isotope designation makes it useful in pharmacokinetic studies. Alogliptin D9 is generally well-tolerated, with common side effects including headache, upper respiratory tract infection, and nasopharyngitis.
Get an Instant Quote
Related Compounds
Alogliptin D3 | Alogliptin 13C D3 | Alogliptin 13C6 |